Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules

Biochemical and Biophysical Research Communications

Volumn 407, Issue 1, 2011, Pages 135-140

  Watanabe, Noriyuki ^a   Aizaki, Hideki ^a   Matsuura, Tomokazu ^b   Kojima, Soichi ^c   Wakita, Takaji ^a   Suzuki, Tetsuro ^d  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RIKEN   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibrosis; HCV; Replicon cells; Stellate cells

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 15; COLLAGEN TYPE 4; COLLAGEN TYPE 5; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VIRUS RNA;

ARTICLE; COPY NUMBER VARIATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA REPLICATION; STELLATE CELL; VIRUS REPLICATION;

EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATIC STELLATE CELLS; HEPATITIS C; HUMANS; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 79953161576     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.125     Document Type: Article

References (33)

1. Pawlotsky J.M. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol. 2004, 12:96-102.
2. Chisari F.V. Unscrambling hepatitis C virus-host interactions. Nature 2005, 436:930-932.
3. Feld J.J., Hoofnagle J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005, 436:967-972.
4. Friedman S.L., Bansal M.B. Reversal of hepatic fibrosis-fact or fantasy?. Hepatology 2006, 43:S82-88.
5. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 2007, 117:539-548.
6. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
7. Bartenschlager R. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. Curr. Opin. Microbiol. 2006, 9:416-422.
8. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285:110-113.
9. Bartosch B., Dubuisson J., Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 2003, 197:633-642.
10. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudo typed retroviral particles. Proc. Natl. Acad. Sci. USA 2003, 100:7271-7276.
11. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11:791-796.
12. Murakami K., Abe T., Miyazawa M., Yamaguchi M., Masuda T., Matsuura T., Nagamori S., Takeuchi K., Abe K., Kyogoku M. Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab. Invest. 1995, 72:731-739.
13. Shibata N., Watanabe T., Okitsu T., Sakaguchi M., Takesue M., Kunieda T., Omoto K., Yamamoto S., Tanaka N., Kobayashi N. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant. 2003, 12:499-507.
14. Miyamoto M., Kato T., Date T., Mizokami M., Wakita T. Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1). Intervirology 2006, 49:37-43.
15. Kato T., Date T., Murayama A., Morikawa K., Akazawa D., Wakita T. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 2006, 1:2334-2339.
16. Takeuchi T., Katsume A., Tanaka T., Abe A., Inoue K., Tsukiyama-Kohara K., Kawaguchi R., Tanaka S., Kohara M. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999, 116:636-642.
17. Wolk B., Buchele B., Moradpour D., Rice C.M. A dynamic view of hepatitis C virus replication complexes. J. Virol. 2008, 82:10519-10531.
18. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 2007, 9:1089-1097.
19. Arthur M.J. Fibrogenesis II, Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G245-G249.
20. Ra H.J., Parks W.C. Control of matrix metalloproteinase catalytic activity. Matrix Biol. 2007, 26:587-596.
21. Date T., Kato T., Miyamoto M., Zhao Z., Yasui K., Mizokami M., Wakita T. Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J. Biol. Chem. 2004, 279:22371-22376.
22. Kato T., Date T., Miyamoto M., Zhao Z., Mizokami M., Wakita T. Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J. Virol. 2005, 79:592-596.
23. Timpe J.M., Stamataki Z., Jennings A., Hu K., Farquhar M.J., Harris H.J., Schwarz A., Desombere I., Roels G.L., Balfe P., McKeating J.A. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 2008, 47:17-24.
24. Witteveldt J., Evans M.J., Bitzegeio J., Koutsoudakis G., Owsianka A.M., Angus A.G., Keck Z.Y., Foung S.K., Pietschmann T., Rice C.M., Patel A.H. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J. Gen. Virol. 2009, 90:48-58.
25. Russell R.S., Meunier J.C., Takikawa S., Faulk K., Engle R.E., Bukh J., Purcell R.H., Emerson S.U. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc. Natl. Acad. Sci. USA 2008, 105:4370-4375.
26. Delgrange D., Pillez A., Castelain S., Cocquerel L., Rouille Y., Dubuisson J., Wakita T., Duverlie G., Wychowski C. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J. Gen. Virol. 2007, 88:2495-2503.
27. Zhong J., Gastaminza P., Chung J., Stamataki Z., Isogawa M., Cheng G., McKeating J.A., Chisari F.V. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 2006, 80:11082-11093.
28. Suzuki K., Nagase H., Ito A., Enghild J.J., Salvesen G. The role of matrix metalloproteinase 3 in the stepwise activation of human rheumatoid synovial procollagenase. Biol. Chem. Hoppe Seyler 1990, 371(Suppl.):305-310.
29. Murphy G., Cockett M.I., Stephens P.E., Smith B.J., Docherty A.J. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem. J. 1987, 248:265-268.
30. Nenan S., Boichot E., Lagente V., Bertrand C.P. Macrophage elastase (MMP-12): a pro-inflammatory mediator?. Mem. Inst. Oswaldo Cruz 2005, 100(Suppl. 1):167-172.
31. Gronski T.J., Martin R.L., Kobayashi D.K., Walsh B.C., Holman M.C., Huber M., Van Wart H.E., Shapiro S.D. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J. Biol. Chem. 1997, 272:12189-12194.
32. Chandler S., Cossins J., Lury J., Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 1996, 228:421-429.
33. Higashi N., Kohjima M., Fukushima M., Ohta S., Kotoh K., Enjoji M., Kobayashi N., Nakamuta M. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells. J. Lab. Clin. Med. 2005, 145:316-322.